EntryPoint Capital LLC bought a new position in shares of Novanta Inc. (NASDAQ:NOVT – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 3,340 shares of the technology company’s stock, valued at approximately $510,000.
Other hedge funds have also added to or reduced their stakes in the company. WCM Investment Management LLC acquired a new stake in shares of Novanta during the fourth quarter worth $15,104,000. Franklin Resources Inc. raised its stake in Novanta by 61.6% in the 3rd quarter. Franklin Resources Inc. now owns 214,893 shares of the technology company’s stock worth $37,916,000 after purchasing an additional 81,942 shares in the last quarter. Geneva Capital Management LLC boosted its holdings in Novanta by 9.3% in the 4th quarter. Geneva Capital Management LLC now owns 852,638 shares of the technology company’s stock valued at $130,257,000 after purchasing an additional 72,592 shares during the period. Vanguard Group Inc. boosted its holdings in Novanta by 1.5% in the 4th quarter. Vanguard Group Inc. now owns 4,123,828 shares of the technology company’s stock valued at $629,997,000 after purchasing an additional 62,585 shares during the period. Finally, Telemark Asset Management LLC grew its position in shares of Novanta by 60.0% during the 4th quarter. Telemark Asset Management LLC now owns 160,000 shares of the technology company’s stock worth $24,443,000 after purchasing an additional 60,000 shares in the last quarter. 98.35% of the stock is owned by institutional investors and hedge funds.
Novanta Price Performance
NOVT stock opened at $137.51 on Tuesday. The company’s 50-day moving average price is $144.13 and its two-hundred day moving average price is $159.50. The firm has a market cap of $4.94 billion, a P/E ratio of 82.34 and a beta of 1.34. The company has a quick ratio of 1.81, a current ratio of 2.79 and a debt-to-equity ratio of 0.61. Novanta Inc. has a 12 month low of $131.03 and a 12 month high of $187.12.
Wall Street Analyst Weigh In
Separately, Robert W. Baird cut their target price on Novanta from $169.00 to $160.00 and set a “neutral” rating for the company in a research report on Monday, March 3rd.
Check Out Our Latest Stock Analysis on Novanta
Novanta Profile
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Featured Articles
- Five stocks we like better than Novanta
- What Are the FAANG Stocks and Are They Good Investments?
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- 3 Warren Buffett Stocks to Buy Now
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.